研究论文

新型一枝蒿酮酸异噁唑衍生物的合成及其抗A, B 型流感病毒活性研究

  • 赵江瑜 ,
  • 阿吉艾克拜尔·艾萨
展开
  • a 中国科学院新疆理化技术研究所 干旱区植物资源化学重点实验室 乌鲁木齐 830011;
    b 中国科学院研究生院 北京 100039

收稿日期: 2011-08-08

  修回日期: 2011-09-14

  网络出版日期: 2012-03-09

基金资助

新疆自治区高技术研究发展计划(No. 200910105)、国家自然科学基金(No. 20872174)和国家杰出青年基金科学(No. 30925045)资助项目.

Synthesis of Novel Isoxazole Contained Rupestonic Acid Derivatives and in vitro Inhibitory Activity against Influenza Viruses A and B

  • ZHAO Jiang-Yu ,
  • Aisa Haji Akber
Expand
  • a Key Laboratory of Chemistry of Plant Resources in Arid Region, Xinjiang Technical Institute of Physics and Chemistry,Chinese Academy of Sciences, Urumqi 830011;
    b Graduate School of Chinese Academy of Sciences, Beijing 100039

Received date: 2011-08-08

  Revised date: 2011-09-14

  Online published: 2012-03-09

Supported by

Project supported by the High-tech Research and Development Program of Xinjiang (No. 200910105), the National Natural Science Foundation of China (No. 20872174) and the China National Science Fund for Distinguished Young Scholars (No. 30925045).

摘要

为了提高一枝蒿酮酸的生物活性, 以一枝蒿酮酸和3-取代苯基-5-氨甲基-异噁唑为原料, 在偶合试剂DCC,HOBt/ DMAP 的作用下, 合成了6 个未见文献报道的含异噁唑的一枝蒿酮酸酰胺衍生物3a3f. 所合成的化合物均经过IR, 1H NMR, 13C NMR, ESI-MS 等分析方法表征及初步体外抗A (H3N2, H1N1)型和B 型流感病毒活性研究. 初步实验结果表明: 化合物3c 同时具有抗A (H3N2)型和B 型流感病毒活性, 化合物3c3e 表现出比母体化合物强的抗B型流感病毒活性.

本文引用格式

赵江瑜 , 阿吉艾克拜尔·艾萨 . 新型一枝蒿酮酸异噁唑衍生物的合成及其抗A, B 型流感病毒活性研究[J]. 有机化学, 2012 , 32(02) : 333 -337 . DOI: 10.6023/cjoc1108081

Abstract

To improve biological activity of rupestonic acid, six rupestonic acid amide derivatives containing isoxazole were synthesized in the presence of DCC, HOBt/DMAP using the rupestonic acid and 3-aryl-5-isoxazole-methylamine as the starting materials. The synthesized compounds 3a3f were confirmed by the methods of 1H NMR, 13C NMR, IR, ESI-MS techniques and preliminarily assayed in vitro against influenza viruses A and B. The results showed that compound 3c showed better activity against both influenza viruses A (H3N2) and B, and compounds 3c and 3e had the higher inhibition against influenza B virus than the parent compound 1.

参考文献

[1] Tosh, P. K.; Poland, G. A. Expert Opin. Emerg. Drugs 2008, 13, 21.

[2] Moscona, A. New Engl. J. Med. 2005, 353, 1363.

[3] Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. Nature 2006, 443, 45.

[4] Mai, L. Q.; Maki, K.; Kazuhiko, S.; Sakai, Y. T.; Hien, N. T.; Nguyen, K. H. L.; Pham, N. D.; Negyn, H. H. Nature 2005, 437, 1108.

[5] Chen, X. Y.; Wang, S. H. Chin. Trad. Herb. Drugs 1981, 12, 25 (in Chinese). (陈希元, 王绍华, 中草药, 1981, 12, 25.)

[6] Zhang, B. H.; Wang, Y. N.; Zhang, Y. Q. Chin. J. Modren Med. 2005, 15, 1968 (in Chinese). (张炳华, 王亚男, 张彦琼, 中国现代医学杂志, 2005, 15, 1968.)

[7] Sirafil; Gulnar; Liu, F. J. Med. Chin. Minorities 1996, 2, 35 (in Chinese). (斯拉甫, 古力娜, 刘发, 中国民族医药杂志, 1996, 2, 35.)

[8] Sirafil; Abdiryim; Gulnar Chin. J. Integr. Trad. Western Med. 2002, 22, 126 (in Chinese). (斯拉甫, 阿不都热依木, 古力娜, 中国中西医结合杂志, 2002, 22, 126.)

[9] Aisa, H. A.; Yong, J. P.; Lv, Q. Y.; Wu, T. Acta Crystallogr. E 2008, 64, o479.

[10] Ma, Y. M.; Aisa, H. A.; Liao, L. X.; Aibai, S.; Zhang, T.; Ito, Y. J. Chromatogr. A 2005, 1076, 198.

[11] Yong, J. P.; Aisa, H. A. Chem. Nat. Compd. 2008, 44, 311.

[12] Yong, J. P.; Aisa, H. A. Chin. J. Org. Chem. 2008, 28, 1807 (in Chinese). (雍建平, 阿吉艾克拜尔·艾萨, 有机化学, 2008, 28, 1807.)

[13] Yong, J. P.; Lv, Q. Y.; Aisa, H. A. Bull. Korean Chem. Soc. 2009, 30, 435.

[14] Tang, L. D.; Wang, J. W.; Zhang, S. J.; Yong, J. P. Chin. Trad. Herb. Drugs 2006, 37, 332 (in Chinese). (汤立达, 王建武, 张士俊, 雍建平, 中草药, 2006, 37, 332.)

[15] Liu, L. J.; Yong, J. P.; Wang, J. W.; Wang, X. Z.; Jia, J. Chem. J. Chin. Univ. 2006, 27, 1669 (in Chinese). (刘利军, 雍建平, 王建武, 王西照, 贾炯, 高等学校化学学报, 2006, 27, 1669.)
文章导航

/